Great to see #NephJC visual abstracts at #GlomConHawaii - this time from @PolskiBarbara
Next time please consider crediting the creator - or show the full VA from @divyaa24 https://t.co/fdZ78crUjI
🧵 HEPATITIS & THE KIDNEY: A Tweetorial for World Hepatitis Day (July 28) 🧵 - by @nephromythri
1/ This #WorldHepatitisDay, let's talk about an organ the liver quietly drags into its problems: the kidney. Hepatitis B and C aren't just liver diseases — they're systemic. Buckle up for 20 tweets. 🫘🦠
Whoops minor error! Here's post one!
#NephJC#TenPostNephJC
FIND-CKD asks: Can we extend nsMRA cardiorenal benefits to the massive population with CKD without diabetes? Let’s FIND out! 🔍
Read the article 👇:
https://t.co/vhp0sl64gv
1/10🧵
👀Seek and you shall FIND 🔎
#ERA26#NephTwitter
FIND-CKD asks if finerenone is beneficial in patients with non-diabetic CKD.
Blog by @ManoleaA & @DivyaveerSSNeph
https://t.co/Xqh51lWpyU
This week we're still catching up with #ERA26
The TRACK study 🛤️🩸 #NephJC#NephTwitter
Check out the VA by @DrSaiVani1
Can low dose rivaroxaban improve CV outcomes in advanced CKD?
https://t.co/E8KKlupuDs
La información también es parte del tratamiento. 💙 Acompáñanos en este live sobre biopsia renal, donde resolveremos las dudas más frecuentes de los pacientes. ¡No faltes! 🩺 #SaludRenal#nefroincich
#NephJC#TenPostNephJC.
#NephTwitter
1/10 Patients with CKD have ⬆️ CVD & bleeding risks but are often excluded from antithrombotic trials, creating a 🔑 evidence gap. Can low dose rivaroxaban safely improve CV outcomes?
https://t.co/DfGbR3wGjc
ÚLTIMOS lugares para el curso de POCUS en Nefrología | NEFRO360 • INCICH
Una experiencia práctica y enfocada en escenarios reales para integrar el ultrasonido en la toma de decisiones del paciente nefrológico crítico. ⚡️